Survival and Late Effects of Children Undergoing Myeloablative Allogeneic HCT at Less Than Three Years of Age: A Report from the Center for International Blood and Marrow Transplant Research

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biology of blood and marrow transplantation 2016-03, Vol.22 (3), p.S28-S29
Hauptverfasser:	Vrooman, Lynda, MD, MSc, Millard, Heather, MPH, Brazauskas, Ruta, PhD, Majhail, Navneet S., MD, MS, Battiwalla, Minoo, MD, MS, Flowers, Mary E.D., MD, Savani, Bipin N., MD, Akpek, Görgün, MD, MHS, Aljurf, Mahmoud D., MD, MPH, Bajwa, Rajinder, MBBS, MRCP, MD, Baker, K. Scott, MD, MS, Beitinjaneh, Amer, MD, MPH, MS, Bitan, Menachem, MD, PhD, Buchbinder, David, MD, Dandoy, Christopher E., MD, MSc, Gale, Robert Peter, MD, PhD, Hayashi, Robert J., MD, Hematti, Peiman, MD, Kamble, Rammurti T., MD, Kasow, Kimberly A., DO, Kletzel, Morris, MD, FAAP, MBA, Lazarus, Hillard M., MD, Malone, Adriana K., MD, O'Brien, Tracey, MD, Olsson, Richard, MD, PhD, Reddy, Vijay, MD, PhD, Willert, Jennifer Reikes, MD, Ringden, Olle, MD, PhD, Schears, Raquel M., MD, MPH, FACEP, Seo, Sachiko, MD, PhD, Steinberg, Amir, MD, Yu, Lolie C., MD, Shaw, Bronwen E., MD, PhD, Duncan, Christine, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Hematology, Oncology and Palliative Medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!